Publish with impact in Cancer Management and Research
Research impact is an important topic in the research world. Funders, institutions, and researchers themselves are all interested in assessing the quality and impact of research.
We’ve curated a collection of published articles from Cancer Management and Research based on their impact within the field—from cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
Explore the science behind these articles and increase your impact as a researcher by becoming our next published author.
Nasopharyngeal carcinoma management
Wai Tong Ng, Barton But, Horace CW Choi, Remco de Bree, Anne WM Lee, Victor HF Lee, Fernando López, Antti A Mäkitie, Juan P Rodrigo, Nabil F Saba, Raymond KY Tsang, Alfio Ferlito
Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Department of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, Oviedo, 33011, Spain; Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, 28029, Spain; Department of Otorhinolaryngology – Head and Neck Surgery, HUS Helsinki University Hospital and University of Helsinki, Helsinki, Finland; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA; Division of Otorhinolaryngology, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China; Coordinator of the International Head and Neck Scientific Group, Padua, Italy
Chemotherapy-free management
Thomas A Ollila, Adam J Olszewski
Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA; Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA
Increase QoL in lung cancer patients
Adriana Hofman, Natalia Zajdel, Jakub Klekowski, Mariusz Chabowski
Student Research Group No 180, Faculty of Medicine, Wroclaw Medical University, Wrocław, Poland; Division of Oncology and Palliative Care, Department of Clinical Nursing, Faculty of Health Science, Wrocław Medical University, Wrocław, Poland; Department of Surgery, 4th Military Teaching Hospital, Wrocław, Poland
Treatment of relapsed follicular lymphoma
Ayushi F Chauhan, Bruce D Cheson
Department of Hematology and Oncology, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington DC, USA; Scientific Advisory Board, Lymphoma Research Foundation, Washington, DC, USA
Myelodysplastic syndromes
Russell Lewis, Jan Philipp Bewersdorf, Amer M Zeidan
Department of Medicine, Section of Hematology, Yale University, New Haven, CT, USA
Treatment of advanced/metastatic melanoma
Stephanie Hawthorne, Linda Zhao, Madelyn Hanson, Gena Kanas, Christine Davis, David Robinson, Matthew Turnure, Otavio Clark
Kantar, Health Division, New York, NY, USA
The beneficial effects of metformin
Pouya Saraei, Ilia Asadi, Muhammad Azam Kakar, Nasroallah Moradi-Kor
Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran; Director Planning and Development, L&DD Department, Quetta, Balochistan, Pakistan; Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran
Neuroendocrine tumors
Michael A Morse, Eric Liu, Vijay N Joish, Lynn Huynh, Mu Cheng, Mei Sheng Duh, Kiernan Seth, Pablo Lapuerta, David C Metz
Duke Cancer Institute, School of Medicine, Duke University, Durham, NC, USA; The Neuroendocrine Institute at Rocky Mountain Cancer Centers, Denver, CO, USA; Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA; 4Analysis Group, Boston, MA, USA; 5Neuroendocrine Tumor Program at Penn Medicine, Philadelphia, PA, USA
Are you interested in publishing your next article with Cancer Management and Research?
Authors are encouraged to send an abstract to obtain a view from the Editor about the suitability of their paper. The Editor will perform a pre-submission check based on subject matter vs the aims and scope of the journal and advise if it is suitable for submission.
Editor-in-Chief: Dr. Kenan Onel
Dr. Onel is an expert in clinical cancer genetics and oversees an active research program to investigate the role of genetics in cancer risk and response to therapy. He is a graduate of Yale University and received both an MD and a PhD in molecular biology from Cornell University Medical College.
Dr. Onel completed his residency in Pediatrics at Babies and Children’s Hospital of New York (Columbia University), a clinical fellowship in Pediatric Hematology/Oncology at the Memorial Sloan-Kettering Cancer Center, and a post-doctoral fellowship in Cancer Genetics at Rockefeller University. Dr. Onel then joined the faculty of The University of Chicago in 2004 where he was an Associate Professor of Pediatrics and Director of the Familial Cancer Clinic.
In 2016, Dr. Onel was recruited to the Zucker School of Medicine at Hofstra/Northwell where he was a Professor of Pediatrics and Genetics and Chief of Medical Genetics and Human Genomics. As of February 2019, Dr. Onel joined the Icahn School of Medicine at Mount Sinai as a Professor of Genetics and Genomic Sciences, and Associate Director of the Tisch Cancer Institute for Clinical Cancer Genetics and Precision Oncology.
Journal Links